RESUMO
In this quasi-experimental study, implementing a procalcitonin and Clinical Pulmonary Infection Score (CPIS) successfully reduced inappropriate antibiotic use among severely-to-critically ill COVID-19 patients, multidrug-resistant organisms, and invasive fungal infections during the intervention period in 2 medical centers. However, this strategy did not improve inappropriate antibiotic use among mildly-to-moderately ill COVID-19 patients.
Assuntos
COVID-19 , Doenças Transmissíveis , Pneumonia , Humanos , Pró-Calcitonina , Antibacterianos/uso terapêutico , Unidades de Terapia Intensiva , Pneumonia/tratamento farmacológico , Doenças Transmissíveis/tratamento farmacológicoRESUMO
We report a case of Nocardia farcinica ruptured intracranial mycotic aneurysm associated with bortezomib and corticosteroid treatment in a multiple myeloma patient. The patient was treated with trimethoprim-sulfamethoxazole and moxifloxacin together with surgical repairment of intracranial mycotic aneurysm.